Skip to content
Wenlo
Sign in
← Markets

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares

144REGNFiled Nov 17, 2026, 4:23 PM ET

AI-generated summary

Director George L. Sing proposed to sell 1,000 shares of Common stock with an aggregate market value of $957,687.10 through Morgan Stanley Smith Barney LLC Executive Financial Services. The sale is approximated to take place on November 17, 2026. The shares were originally acquired on April 9, 1991.

Key facts

Seller
GEORGE L. SING
Relationship
Director
Shares to sell
1,000
Market value
$957,687.10
Approximate sale date
Nov 17, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired
Apr 9, 1991 · Private Acquisition from Issuer/Affiliate

More REGN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.